Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the U.S., Canada, and Europe, a diverse pipeline of early- to late-stage assets, and in-house advanced technology capabilities, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com (https://c212.net/c/link/?t=0&l=en&o=4190475-1&h=3440496098&u=https%3A%2F%2Fwww.us.sumitomo-pharma.com%2F&a=https%3A%2F%2Fwww.us.sumitomo-pharma.com+) or follow us on LinkedIn (https://c212.net/c/link/?t=0&l=en&o=4190475-1&h=2504638834&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsumitomo-pharma-america%2F&a=LinkedIn) .

Job Overview

We are currently seeking a dynamic, highly motivated, and experienced individual for the position of Senior Director, Commercial Strategy and Launch Lead, Heme/Onc.

Job Duties and Responsibilities

Identify and characterize market opportunities and drivers of commercial value

• Partner with Commercial Insights and Analytics (CI&A) to develop insight into the market, customers, stakeholders and competition for enzomenib through primary and secondary data analysis, competitive intelligence and business analytics

• Propose and conduct market research to understand current treatment journey and identify customer (physician, payer and patient) needs to support enzomenib adoption

• Provide market/ commercialization perspective to clinical development program teams to refine target product profile (TPP), shape value proposition, differentiation strategy and ensure reimbursable label at launch

• Ensure commercial needs are considered in decision-making for registrational trials, developing real world evidence (RWE) and lifecycle management (LCM) strategies

• Build internal awareness and provide training to cross-functional teams on product and market

Create preliminary integrated brand plan for enzomenib

• Develop commercial launch and long-term strategies that optimize enzomenib value across product lifecycle

• Develop market development strategy to identify and address opportunities and barriers to enzomenib adoption across customer segments (physician, payer, patient)

• Lead the development and implementation of marketing plans that include situational analyses, segmentation and go-to-market strategies

• Partner with market access (strategic pricing & contracting and trade group) to develop launch pricing, access and distribution strategy for enzomenib taking into consideration the long-term lifecycle of brand

• Partner with Market Access to formulate and shape HEOR data/evidence generation needs to support enzomenib launch and commercialization

• Understand the companion diagnostic landscape and develop CDx commercial approach for enzomenib

• Partner with sales and market access leadership to propose customer facing model and roles for enzomenib, considering current and future Oncology portfolio synergies

• Provide requirements for commercial product including pill size, shape/color, packaging, sample and labeling needs to Technology and Quality to ensure commercial product is available for launch

• Identify and establish organizational capabilities required to bring product to market and demonstrate value

• Prepare and present pre-commercialization brand strategy to senior leadership

• Develop core brand messaging, marketing campaigns and tactics to support achievement of commercial goals

Financial Forecast and Operating Budget

• Partner with the forecasting and CI&A teams to develop the launch and long-range forecast for enzomenib

• Evaluate different launch options using NPV and ROI analysis

• Partner with finance to develop and maintain the operating budgets for enzomenib

• Participate in portfolio strategy and commercial evaluation of other Oncology pipeline assets as required; partner with Business Development (BD) as required on evaluation of BD opportunities

Medical Affairs Strategic Alignment and Partnership

• Partner with Medical Affairs on our approach to supporting the patients we serve, and collaborate on developing the Patient Advocacy strategy and implementation, and ensure patient voice is represented into the TPP

• Partner with Medical Affairs on key initiatives including KOL identification and development, publication planning and RWE strategy and LCM

• Work cross functionally on planning medical congresses, advisory boards, disease education/awareness initiatives, speaker programs.

Education and Experience

• BS/BA degree in business or related discipline required, MBA preferred

• Minimum of 15 years of relevant pharmaceutical or biotechnology industry

• Oncology launch experience required, experience in AML and launching with companion diagnostics strongly preferred

• Experience in building and leading cross-functional brand teams; experience in building and leading marketing teams

• Comfortable working in a fast-paced environment while working, building and leading in a remote setting

• Must be highly analytical and comfortable formulating and delivering data-driven, fact-based analyses of the business and using these insights to propose effective strategies to meet brand and corporate objectives

• Excellent interpersonal and communication skills

• Ability to synthesize data, deliver key messages and recommended action plans

• Strong executive presence and comfortable interacting and presenting to C-suite members

• Experience in attracting and developing top talent with diverse backgrounds

• Highly skilled in working and leading cross-functionally with internal and external stakeholders

• Able to adapt to changes in the work environment, ambiguity and managing demands

The base salary range for this role is $224,000 to $280,000. Base salary is part of our total rewards package which also includes the opportunity for merit-based salary increases, short incentive plan participation, eligibility for our 401(k) plan, medical, dental, vision, life and disability insurances and leaves provided in line with your work state. Our robust time-off policy includes flexible paid time off, 11 paid holidays plus additional time off for a shut-down period during the last week of December, 80 hours of paid sick time upon hire and each year thereafter. Total compensation, including base salary to be offered, will depend on elements unique to each candidate, including candidate experience, skills, education and other factors permitted by law.

Disclaimer: The above statements are intended to describe the general nature and level of work being performed by people assigned to this classification. They are not to be construed as an exhaustive list of all responsibilities, duties, and skills required of personnel so classified. All personnel may be required to perform duties outside of their normal responsibilities from time to time, as needed.

Confidential Data : All information (written, verbal, electronic, etc.) that an employee encounters is considered confidential.

Compliance : Achieve and maintain Compliance with all applicable regulatory, legal and operational rules and procedures, by ensuring that all plans and activities for and on behalf of Sumitomo Pharma America (SMPA) and affiliates are carried out with the "best" industry practices and the highest ethical standards.

Mental/Physical Requirements : Fast paced environment handling multiple demands. Must be able to exercise appropriate judgment as necessary. Requires a high level of initiative and independence. Excellent written and oral communication skills required. Requires ability to use a personal computer for extended periods of time.

Sumitomo Pharma America (SMPA) is an Equal Employment Opportunity (EEO) employer

Qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

Sumitomo Pharma Co., Ltd. is a global pharmaceutical company based in Japan with key operations in the U.S. (Sumitomo Pharma America, Inc.), Canada (Sumitomo Pharma Canada, Inc.) and Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology, urology, women's health, rare diseases, psychiatry & neurology, and cell & gene therapies. With several marketed products in the U.S., Canada, and Europe, a diverse pipeline of early- to late-stage assets, and in-house advanced technology capabilities, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com (https://c212.net/c/link/?t=0&l=en&o=4190475-1&h=3440496098&u=https%3A%2F%2Fwww.us.sumitomo-pharma.com%2F&a=https%3A%2F%2Fwww.us.sumitomo-pharma.com+) or follow us on LinkedIn (https://c212.net/c/link/?t=0&l=en&o=4190475-1&h=2504638834&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsumitomo-pharma-america%2F&a=LinkedIn) .

At Sumitomo Pharma America, our work is guided by the Sumitomo Pharma mission, vision and values, which tie closely to our company’s cultural pillars.

Our Mission

To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide

Our Vision

For Longer and Healthier Lives, we unlock the future with cutting edge technology and ideas